P

Inventor

BAUST LISA

DE22 patents
⚠️ This page may combine multiple inventors who share the name “BAUST LISA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE BIOTECHNOLOGY LTD

19 patents
US9114166B2Aug 25, 2015

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD67 citations99
US8916157B2Dec 23, 2014

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD91 citations99
US9738714B2Aug 22, 2017

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD22 citations98
US9272041B2Mar 1, 2016

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD30 citations98
US8802101B2Aug 12, 2014

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD35 citations98
US9327032B2May 3, 2016

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD17 citations96
US9302011B2Apr 5, 2016

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD17 citations96
US9295725B2Mar 29, 2016

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD17 citations96
US9289497B2Mar 22, 2016

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD17 citations96
US9272042B2Mar 1, 2016

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD17 citations96
US9220781B2Dec 29, 2015

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD19 citations96
US8940305B2Jan 27, 2015

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD27 citations96
US8916158B2Dec 23, 2014

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD31 citations96
US8911741B2Dec 16, 2014

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD26 citations96
US8802102B2Aug 12, 2014

Formulation of human antibodies for treating TNF-α associated disorders

ABBVIE BIOTECHNOLOGY LTD26 citations96
US8795670B2Aug 5, 2014

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD27 citations96
US9950066B2Apr 24, 2018

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD8 citations92
US9750808B2Sep 5, 2017

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD10 citations92
US9732152B2Aug 15, 2017

Formulation of human antibodies for treating TNF-alpha associated disorders

ABBVIE BIOTECHNOLOGY LTD8 citations92

KRAUSE HANS-JUERGEN

1 patent

ABBVIE BIOTENCHOLOGY LTD

1 patent

KRUASE HANS-JUERGEN

1 patent